UK markets closed

Celcuity Inc. (CELC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
16.30+0.53 (+3.36%)
At close: 04:00PM EDT
15.95 -0.35 (-2.15%)
After hours: 04:06PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close15.77
Open15.84
Bid16.20 x 100
Ask16.32 x 100
Day's range15.50 - 16.40
52-week range8.39 - 22.19
Volume354,389
Avg. volume232,124
Market cap496.386M
Beta (5Y monthly)0.79
PE ratio (TTM)N/A
EPS (TTM)-2.69
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est28.60
  • GlobeNewswire

    Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

    MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences: A fireside chat at the 23rd Annual Needham Virtual Healthcare Conference at 2:15 p.m. ET on Thursday, April 11, 2024. A live webcast w

  • Simply Wall St.

    Celcuity Gains 12%, Insider Trades Reap Benefit

    Insiders who bought Celcuity Inc. ( NASDAQ:CELC ) stock in the last 12 months were richly rewarded last week. The...

  • Insider Monkey

    Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript

    Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript March 27, 2024 Celcuity Inc. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.71. CELC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to […]